Magen BioSciences Overview

  • Year Founded
  • 2006

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 16

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $14.9M

Magen BioSciences General Information

Description

Developer of pharmaceutical products designed to improve the human skin. The company's products are made using a science-driven approach grounded in a deep understanding of the underlying biology of normal and diseased skin, enabling users to improve the health and appearance of human skin.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 100 Beaver Street
  • Suite 101
  • Waltham, MA 02453
  • United States
Primary Industry
Pharmaceuticals
Other Industries
Other Healthcare Services
Vertical(s)
Corporate Office
  • 100 Beaver Street
  • Suite 101
  • Waltham, MA 02453
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Magen BioSciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 03-Apr-2009 $14.9M Completed Generating Revenue
2. Early Stage VC (Series A) 28-Aug-2006 Completed Generating Revenue
1. Seed Round 21-Mar-2006 $1.8M $1.8M Completed Startup
To view Magen BioSciences’s complete valuation and funding history, request access »

Magen BioSciences Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Magen BioSciences Former Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
ARCH Venture Partners Venture Capital Minority
Alexandria Venture Investments Venture Capital Minority
Bock Family Ventures Venture Capital Minority
Flybridge (New York) Venture Capital Minority
Highland Capital Partners Venture Capital Minority
You’re viewing 5 of 9 investors. Get the full list »

Magen BioSciences FAQs

  • When was Magen BioSciences founded?

    Magen BioSciences was founded in 2006.

  • Where is Magen BioSciences headquartered?

    Magen BioSciences is headquartered in Waltham, MA.

  • What is the size of Magen BioSciences?

    Magen BioSciences has 16 total employees.

  • What industry is Magen BioSciences in?

    Magen BioSciences’s primary industry is Pharmaceuticals.

  • Is Magen BioSciences a private or public company?

    Magen BioSciences is a Private company.

  • What is the current valuation of Magen BioSciences?

    The current valuation of Magen BioSciences is .

  • What is Magen BioSciences’s current revenue?

    The current revenue for Magen BioSciences is .

  • How much funding has Magen BioSciences raised over time?

    Magen BioSciences has raised $17.2M.

  • Who are Magen BioSciences’s investors?

    ARCH Venture Partners, Alexandria Venture Investments, Bock Family Ventures, Flybridge (New York), and Highland Capital Partners are 5 of 9 investors who have invested in Magen BioSciences.

  • When was Magen BioSciences acquired?

    Magen BioSciences was acquired on 03-Apr-2009.

  • Who acquired Magen BioSciences?

    Magen BioSciences was acquired by Pharmaceutical Product Development.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process